Meanwhile, cystatin C-positive neuroendocrine-like cells were stronger in prostate cancer than in benign tissues, suggesting a link between cystatin C and neuroendocrine differentiation in prostate cancer progression. This evidence concerns the gene CST3 and prostate carcinoma.